View on Pubmed.gov 22318161 | View on doi.org 10.1136/thoraxj...
Significance of the microbiome in obstructive lung disease.
- Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, 3916 Taubman Center, Box 5360, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5360, USA. mrking@umich.edu
Abstract
The composition of the lung microbiome contributes to both health and disease, including obstructive lung disease. Because it has been estimated that over 70% of the bacterial species on body surfaces cannot be cultured by currently available techniques, traditional culture techniques are no longer the gold standard for microbial investigation. Advanced techniques that identify bacterial sequences, including the 16S ribosomal RNA gene, have provided new insights into the depth and breadth of microbiota present both in the diseased and normal lung. In asthma, the composition of the microbiome of the lung and gut during early childhood development may play a key role in the development of asthma, while specific airway microbiota are associated with chronic asthma in adults. Early bacterial stimulation appears to reduce asthma susceptibility by helping the immune system develop lifelong tolerance to innocuous antigens. By contrast, perturbations in the microbiome from antibiotic use may increase the risk for asthma development. In chronic obstructive pulmonary disease, bacterial colonisation has been associated with a chronic bronchitic phenotype, increased risk of exacerbations, and accelerated loss of lung function. In cystic fibrosis, studies utilising culture-independent methods have identified associations between decreased bacterial community diversity and reduced lung function; colonisation with Pseudomonas aeruginosa has been associated with the presence of certain CFTR mutations. Genomic analysis of the lung microbiome is a young field, but has the potential to define the relationship between lung microbiome composition and disease course. Whether we can manipulate bacterial communities to improve clinical outcomes remains to be seen.
References
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20529-33
Cell Host Microbe. 2008 Oct 16;4(4):337-49
ISME J. 2011 May;5(5):780-91
Expert Rev Anti Infect Ther. 2006 Feb;4(1):101-24
Cited by 220 citations (total)
Journal Article Research Support, N.I.H., Extramural Review
The microbiome in wound repair and tissue fibrosis.
Electronic publication date February 8, 2013
Brittan S Scales [...] Gary B Huffnagle et al.
Bacterial colonization occurs in all wounds, chronic or acute, and the break in epithelium integrity that defines a wound impairs...
Journal Article
The human microbiota: a new direction in the investigation of thoracic diseases.
Electronic publication date August 27, 2013
Anselm Wang-Hei Hui [...] Stephen Kwok-Wing Tsui et al.
Advancements in next generation sequencing technology have provided means for the comprehensive profiling of the microbial community in the respiratory...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •